wordpress blog stats
Connect with us

Hi, what are you looking for?

FDA to launch pilot blockchain network with IBM, KPMG, Walmart and Merck for drugs traceability

The US Food and Drug Administration (FDA) earlier this month selected IBM, Merck, KPMG and Walmart to participate in a pilot programme to create a proof-of-concept blockchain network to enhance the security of drugs supply chain, as per a joint release by the companies. The pilot has been authorised under the US Drug Supply Chain Security Act (DSCSA), which aims to establish a regulatory oversight framework to regulate counterfeit, stolen, contaminated, or otherwise harmful drugs. Drug diversion — when prescription drugs are hijacked from the legal market — is a major and costly dilemma plaguing the healthcare industry: nearly 19 million pills, worth up to $164 million went missing in the first half of 2018. “DSCSA was enacted by Congress on Nov. 27, 2013. It outlines steps to build an electronic, interoperable system to identify and trace certain prescription drugs as they are distributed in the United States. The DSCSA pilot project program is intended to help identify and evaluate the most efficient processes to comply with and apply drug supply chain security requirements.” The project is scheduled to be completed in the fourth quarter of 2019, and outcomes will be published in a report. The project’s focus will be on the DSCSA's requirement to develop the interoperable track-and-trace system for the distribution of prescription drugs by November 2023. The companies and FDA expect to address multiple gaps in the supply chain process, including a speedy framework for tracking inventory, sharing of accurate data among stakeholders, and assuring the integrity…

Please subscribe/login to read the full story.
Written By

Blogger at MediaNama. Personal blogs at www.lawforit.wordpress.com.

MediaNama’s mission is to help build a digital ecosystem which is open, fair, global and competitive.

Views

News

India's smartphone operating system BharOS has received much buzz in the media lately, but does it really merit this attention?

News

After using the Mapples app as his default navigation app for a week, Sarvesh draws a comparison between Google Maps and Mapples

News

In the case of the ‘deemed consent' provision in the draft data protection law, brevity comes at the cost of clarity and user protection

News

The regulatory ambivalence around an instrument so essential to facilitate data exchange – the CM framework – is disconcerting for several reasons.

News

The provisions around grievance redressal in the Data Protection Bill "stands to be dangerously sparse and nugatory on various counts."

You May Also Like

News

Google has released a Google Travel Trends Report which states that branded budget hotel search queries grew 179% year over year (YOY) in India, in...

Advert

135 job openings in over 60 companies are listed at our free Digital and Mobile Job Board: If you’re looking for a job, or...

News

By Aroon Deep and Aditya Chunduru You’re reading it here first: Twitter has complied with government requests to censor 52 tweets that mostly criticised...

News

Rajesh Kumar* doesn’t have many enemies in life. But, Uber, for which he drives a cab everyday, is starting to look like one, he...

MediaNama is the premier source of information and analysis on Technology Policy in India. More about MediaNama, and contact information, here.

© 2008-2021 Mixed Bag Media Pvt. Ltd. Developed By PixelVJ

Subscribe to our daily newsletter
Name:*
Your email address:*
*
Please enter all required fields Click to hide
Correct invalid entries Click to hide

© 2008-2021 Mixed Bag Media Pvt. Ltd. Developed By PixelVJ